A young life tragically lost, but could it have been prevented? The death of Chimamanda Ngozi Adichie's son, Nkanu, has sparked a crucial debate in the medical community, with pharmacists sounding the alarm over the use of propofol and demanding answers.
The Pharmacists' Plea for Accountability:
The Association of Hospital and Administrative Pharmacists of Nigeria (AHAPN) has issued a powerful statement, calling Nkanu's death a 'grave patient-safety failure' that requires urgent national attention. They argue that the circumstances surrounding his death reveal a critical breach of internationally recognized safety standards.
A Deviation from Global Guidelines:
Here's where it gets controversial. AHAPN's National Chairman, Pharm. Elechi Oyim, claims that propofol, a powerful sedative, was administered continuously to a child under three years old. This, he asserts, goes against global guidelines, as prolonged propofol infusion in young children is known to carry a significant risk of Propofol Infusion Syndrome (PRIS), a deadly complication.
The Risks of PRIS:
PRIS is no minor concern. It's associated with severe metabolic acidosis, muscle deterioration, heart failure, and sudden death. Major health organizations, including the World Health Organization (WHO) and the U.S. Food and Drug Administration (FDA), have explicitly warned against the prolonged use of propofol in pediatric intensive care due to PRIS-related fatalities.
A Call for Systemic Change:
AHAPN's concerns go beyond this tragic case. They highlight a systemic issue in Nigeria's healthcare governance. Oyim argues that the exclusion of pharmacists from critical care decisions is a dangerous oversight, as pharmacists are trained to identify unsafe drug choices, monitor dosage, and intervene to prevent fatal outcomes. He believes this exclusion is a governance failure, not just a clinical one.
The Need for Multidisciplinary Oversight:
'Medication safety is a shared responsibility,' Oyim emphasizes. He advocates for structured multidisciplinary oversight when using high-risk drugs like anesthetics. This call for reform aims to protect vulnerable pediatric patients, who legally and ethically should never be exposed to avoidable pharmacological risks.
A Call to Action:
AHAPN demands a thorough, transparent investigation into Nkanu's death and urgent reforms to enhance medication governance in Nigerian hospitals. They argue that failing to adhere to international safety standards not only puts lives at risk but also increases institutional and legal liability.
But what do you think? Is this a wake-up call for healthcare systems worldwide to re-evaluate their practices? Or is it an isolated incident that doesn't warrant such drastic measures? Share your thoughts below, and let's spark a constructive dialogue on patient safety and medical accountability.
